Polo-like kinase (PLK) 5, a new member of the PLK family, serves as a biomarker to indicate anabatic tumor burden and poor prognosis for resectable non-small cell lung cancer

Polo-like kinase (PLK) 5, a new member of the PLK family, serves as a biomarker to indicate anabatic tumor burden and poor prognosis for resectable non-small cell lung cancer

ObjectiveA review argues that polo-like kinase 5 (PLK5) may be linked to unfavorable prognosis in non-small cell lung cancer (NSCLC) patients, which contradicts the discoveries from The Human Protein Atlas database (derived from TCGA analysis). This study intended to comprehensively confirm the asso...

Full description

Bibliographic Details
Main Authors: Kaichao Wang, Shaohui Shen, Liyuan Dong, Qinmo Fang, Xinlei Hou, Xueliang Shi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Surgery
Subjects:
polo-like kinase 5
non-small cell lung cancer
clinical characteristics
disease-free survival
overall survival
Online Access:https://www.frontiersin.org/articles/10.3389/fsurg.2022.964044/full

Internet

https://www.frontiersin.org/articles/10.3389/fsurg.2022.964044/full

Similar Items